BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+95.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$4.87M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
85
New
Increased
Reduced
Closed

Top Buys

1
+$3.05M
2
+$2.52M
3
+$2.23M
4
RLMD icon
Relmada Therapeutics
RLMD
+$1.94M
5
CLDX icon
Celldex Therapeutics
CLDX
+$1.91M

Top Sells

1
+$3.6M
2
+$2.93M
3
+$2.22M
4
IMNM icon
Immunome
IMNM
+$1.78M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$1.77M

Sector Composition

1 Healthcare 73.14%
2 Technology 21.04%
3 Energy 4.89%
4 Materials 0.6%
5 Financials 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KLAC icon
1
KLA
KLAC
$278B
$29.3M 16.67%
19,883
-2,000
BMY icon
2
Bristol-Myers Squibb
BMY
$112B
$18.6M 10.57%
306,268
+3,426
CMPX icon
3
Compass Therapeutics
CMPX
$378M
$7.75M 4.41%
1,465,867
-127,071
LRCX icon
4
Lam Research
LRCX
$430B
$7.69M 4.38%
36,000
-4,329
STOK icon
5
Stoke Therapeutics
STOK
$1.83B
$6.84M 3.89%
210,000
-50,000
OVV icon
6
Ovintiv
OVV
$16.6B
$6.38M 3.63%
107,500
NTLA icon
7
Intellia Therapeutics
NTLA
$1.82B
$5.71M 3.25%
445,400
+130,000
GPCR icon
8
Structure Therapeutics
GPCR
$2.67B
$4.82M 2.74%
100,000
+10,000
SLDB icon
9
Solid Biosciences
SLDB
$674M
$4.51M 2.57%
625,980
-79,975
PRTA icon
10
Prothena Corp
PRTA
$467M
$4.36M 2.48%
449,019
+8,000
BDSX icon
11
Biodesix
BDSX
$167M
$4.16M 2.37%
286,804
ACAD icon
12
Acadia Pharmaceuticals
ACAD
$3.67B
$3.81M 2.17%
171,000
PTGX icon
13
Protagonist Therapeutics
PTGX
$6.14B
$3.69M 2.1%
35,000
-20,000
NBIX icon
14
Neurocrine Biosciences
NBIX
$16.6B
$3.58M 2.04%
27,190
OLMA icon
15
Olema Pharmaceuticals
OLMA
$918M
$3.27M 1.86%
219,000
-50,000
RLMD icon
16
Relmada Therapeutics
RLMD
$664M
$2.85M 1.62%
+409,387
OCUL icon
17
Ocular Therapeutix
OCUL
$1.83B
$2.71M 1.54%
+320,000
UTHR icon
18
United Therapeutics
UTHR
$23.3B
$2.67M 1.52%
4,500
+1,500
NKTR icon
19
Nektar Therapeutics
NKTR
$2B
$2.23M 1.27%
31,000
CLDX icon
20
Celldex Therapeutics
CLDX
$2.34B
$2.22M 1.27%
+70,095
NVCR icon
21
NovoCure
NVCR
$1.87B
$2.21M 1.26%
202,330
+50,230
EQT icon
22
EQT Corp
EQT
$34.1B
$2.2M 1.25%
34,619
PHAT icon
23
Phathom Pharmaceuticals
PHAT
$805M
$2.17M 1.23%
195,000
BCYC
24
Bicycle Therapeutics
BCYC
$293M
$2.15M 1.22%
463,599
+899
CMPS
25
Compass Pathways
CMPS
$1.71B
$2.07M 1.18%
+375,000
1
2 3 4